Annual accounts receivable:
$358.00M-$534.00M(-59.87%)Summary
- As of today (May 20, 2025), MRNA annual accounts receivable is $358.00 million, with the most recent change of -$534.00 million (-59.87%) on December 31, 2024.
- During the last 3 years, MRNA annual accounts receivable has fallen by -$2.82 billion (-88.72%).
- MRNA annual accounts receivable is now -88.72% below its all-time high of $3.17 billion, reached on December 31, 2021.
Performance
MRNA Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$78.00M-$280.00M(-78.21%)Summary
- As of today (May 20, 2025), MRNA quarterly accounts receivable is $78.00 million, with the most recent change of -$280.00 million (-78.21%) on March 31, 2025.
- Over the past year, MRNA quarterly accounts receivable has dropped by -$59.00 million (-43.07%).
- MRNA quarterly accounts receivable is now -97.58% below its all-time high of $3.22 billion, reached on March 31, 2021.
Performance
MRNA Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
MRNA Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -59.9% | -43.1% |
| 3 y3 years | -88.7% | -97.5% |
| 5 y5 years | +3683.6% | +643.0% |
MRNA Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -88.7% | at low | -97.5% | at low |
| 5 y | 5-year | -88.7% | +3683.6% | -97.6% | +643.0% |
| alltime | all time | -88.7% | >+9999.0% | -97.6% | >+9999.0% |
MRNA Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $78.00M(-78.2%) |
| Dec 2024 | $358.00M(-59.9%) | $358.00M(-77.1%) |
| Sep 2024 | - | $1.56B(+859.5%) |
| Jun 2024 | - | $163.00M(+19.0%) |
| Mar 2024 | - | $137.00M(-84.6%) |
| Dec 2023 | $892.00M(-35.6%) | $892.00M(-52.2%) |
| Sep 2023 | - | $1.87B(+704.3%) |
| Jun 2023 | - | $232.00M(-79.2%) |
| Mar 2023 | - | $1.11B(-19.6%) |
| Dec 2022 | $1.39B(-56.4%) | $1.39B(-48.6%) |
| Sep 2022 | - | $2.69B(+0.1%) |
| Jun 2022 | - | $2.69B(-15.2%) |
| Mar 2022 | - | $3.17B(-0.1%) |
| Dec 2021 | $3.17B(+128.3%) | $3.17B(+1.1%) |
| Sep 2021 | - | $3.14B(+55.5%) |
| Jun 2021 | - | $2.02B(-37.3%) |
| Mar 2021 | - | $3.22B(+131.5%) |
| Dec 2020 | $1.39B(>+9900.0%) | $1.39B(+583.7%) |
| Sep 2020 | - | $203.44M(+304.1%) |
| Jun 2020 | - | $50.34M(+379.6%) |
| Mar 2020 | - | $10.50M(+10.9%) |
| Dec 2019 | $9.46M(-58.3%) | $9.46M(-47.8%) |
| Sep 2019 | - | $18.12M(+67.3%) |
| Jun 2019 | - | $10.83M(-39.7%) |
| Mar 2019 | - | $17.95M(-20.8%) |
| Dec 2018 | $22.67M(+49.5%) | $22.67M(+96.2%) |
| Sep 2018 | - | $11.56M(-23.8%) |
| Dec 2017 | $15.16M(+12.1%) | $15.16M(>+9900.0%) |
| Dec 2016 | $13.52M(+2604.6%) | - |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(-100.0%) |
| Dec 2014 | $500.00K(+9900.0%) | $500.00K(>+9900.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(-100.0%) |
| Dec 2013 | $5000.00(-28.6%) | $5000.00(0.0%) |
| Sep 2013 | - | $5000.00(0.0%) |
| Jun 2013 | - | $5000.00(0.0%) |
| Mar 2013 | - | $5000.00(-28.6%) |
| Dec 2012 | $7000.00 | $7000.00(-97.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $250.00K(>+9900.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2011 | - | $10.00K(+100.0%) |
| Jun 2011 | - | $5000.00(>+9900.0%) |
| Mar 2011 | - | $0.00(-100.0%) |
| Dec 2010 | $59.00K(-72.0%) | $59.00K(-72.0%) |
| Sep 2010 | - | $211.00K(+91.8%) |
| Jun 2010 | - | $110.00K(-13.4%) |
| Mar 2010 | - | $127.00K(-39.8%) |
| Dec 2009 | $211.00K(+559.4%) | $211.00K(+330.6%) |
| Sep 2009 | - | $49.00K(-18.3%) |
| Jun 2009 | - | $60.00K(+361.5%) |
| Mar 2009 | - | $13.00K(-59.4%) |
| Dec 2008 | $32.00K(-90.1%) | $32.00K(-91.7%) |
| Jun 2008 | - | $385.00K(+9.1%) |
| Mar 2008 | - | $353.00K(+9.0%) |
| Dec 2007 | $324.00K(-88.4%) | $324.00K(+161.3%) |
| Sep 2007 | - | $124.00K(-65.6%) |
| Jun 2007 | - | $360.00K(-55.9%) |
| Mar 2007 | - | $816.00K(-70.8%) |
| Dec 2006 | $2.80M(+1380.4%) | $2.80M(+8.1%) |
| Sep 2006 | - | $2.59M(+100.9%) |
| Jun 2006 | - | $1.29M(-16.7%) |
| Mar 2006 | - | $1.55M(+719.0%) |
| Dec 2005 | $189.00K(+112.4%) | $189.00K(-67.5%) |
| Sep 2005 | - | $582.00K(-34.5%) |
| Jun 2005 | - | $888.00K(+7.6%) |
| Mar 2005 | - | $825.00K(-83.8%) |
| Sep 2004 | - | $5.09M(+4487.4%) |
| Mar 2004 | - | $111.00K(+24.7%) |
| Dec 2003 | $89.00K(-88.1%) | $89.00K(+345.0%) |
| Sep 2003 | - | $20.00K(-62.3%) |
| Jun 2003 | - | $53.00K(-89.0%) |
| Mar 2003 | - | $483.00K(-35.2%) |
| Dec 2002 | $745.00K(+949.3%) | $745.00K(+709.8%) |
| Jun 2002 | - | $92.00K(+26.0%) |
| Mar 2002 | - | $73.00K(+2.8%) |
| Dec 2001 | $71.00K | $71.00K(-18.4%) |
| Sep 2001 | - | $87.00K(+1.2%) |
| Jun 2001 | - | $86.00K(+132.4%) |
| Mar 2001 | - | $37.00K |
FAQ
- What is Moderna annual accounts receivable?
- What is the all time high annual accounts receivable for Moderna?
- What is Moderna annual accounts receivable year-on-year change?
- What is Moderna quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Moderna?
- What is Moderna quarterly accounts receivable year-on-year change?
What is Moderna annual accounts receivable?
The current annual accounts receivable of MRNA is $358.00M
What is the all time high annual accounts receivable for Moderna?
Moderna all-time high annual accounts receivable is $3.17B
What is Moderna annual accounts receivable year-on-year change?
Over the past year, MRNA annual accounts receivable has changed by -$534.00M (-59.87%)
What is Moderna quarterly accounts receivable?
The current quarterly accounts receivable of MRNA is $78.00M
What is the all time high quarterly accounts receivable for Moderna?
Moderna all-time high quarterly accounts receivable is $3.22B
What is Moderna quarterly accounts receivable year-on-year change?
Over the past year, MRNA quarterly accounts receivable has changed by -$59.00M (-43.07%)